期刊文献+

产超广谱β-内酰胺酶大肠埃希菌及肺炎克雷伯菌对九种抗菌药物的耐药性分析 被引量:4

Resistance of ESBLs-producing Echerichia coli and Klebsiella pneumoniae to 9 antimicrobial agents
下载PDF
导出
摘要 目的 了解肺炎克雷伯菌和大肠埃希菌产超广谱 β 内酰胺酶 (ESBLs)菌株的检出率及耐药性。方法 采用琼脂稀释法对 2 0 0 1年 4月~ 2 0 0 2年 2月四川大学华西医院从临床标本中分离的非重复大肠埃希菌和肺炎克雷伯菌进行产ESBLs株的初筛 ,用NCCLS推荐的纸片扩散法作确证试验 ,并测定产ESBLs株对 9种抗菌药物的MIC值。结果 大肠埃希菌及肺炎克雷伯菌产ESBLs株的检出率分别为 2 6.4%和 18.2 %。产ESBLs菌株多呈多重耐药 ,耐药性由高至低依次为环丙沙星 (93 .3 % )、头孢噻肟 (70 % )、头孢哌酮 /舒巴坦 (66.7% )、氨曲南 (63 .3 % )、阿米卡星 (3 6.7% )、头孢西丁 (2 0 % )、头孢他定 (16.7% )、头孢吡肟 (10 % ) ,亚胺培南 10 0 %敏感。结论 产ES BLs细菌多呈多重耐药。 Objective To survey the prevalence and the resistance of ESBLs-producing Klebsiella pneumoniae and Escherichia coli isolated in Sichuan University Huaxi Medical Center.Methods The ESBLs-producing Klebsiella pneumoniae and Escherichia coli were isolated from clinical species in West China HospitalSichuan University from April,2001 to February,2002,and were screened and confirmed by agar dilution and double disk diffusion according to NCCLS.The MICs of nine kinds of antibiotics against the ESBLs-producing clinical isolates were detected by agar dilution.Results The incidence of ESBLs-producing K. pneumoniae and E.coli are 18.2% and 26.4% respectively.Most of the ESBLs producing strains were multidrug resistance.Their resistant rates to ciprofloxacin,aztreonam,cefoperazone/sulbactam were higher than to other drugs.All ESBLs-producing strains were susceptible to imipenem.Conclusion The incidence of ESBLs-producing strain was rather high.Most of the ESBLs-producing strains were multidrug resistance,and imipenem is still the best antibiotic for treatment of the infections caused by ESBLs-producing bacteria.
出处 《临床内科杂志》 CAS 北大核心 2003年第11期574-576,共3页 Journal of Clinical Internal Medicine
基金 教育部高等学校博士学科点专项科研基金(NO.9847)
关键词 超广谱Β-内酰胺酶 琼脂稀释法 耐药性 多重耐药 Extended-spectrum β-lactamases Agar dilution Resistance Multidrug resistance
  • 相关文献

参考文献3

二级参考文献7

共引文献50

同被引文献23

  • 1曾贱高,刘利辉,张华,李龙平.1 055株革兰阴性杆菌菌种分布及耐药性分析[J].中国感染控制杂志,2006,5(1):62-64. 被引量:24
  • 2Thomson KS. Minimizing quinolone resistance:are the new agent smote or Iess Iikely to cause resistance[J].Antimicrob Chemoth-er, 2000,45(4): 719-723.
  • 3Rupp ME,Fey PD.Extended spectrum β-Lactamase(ESBL)-producing Enterobacteriaceae considerations for diagnosis ,prevention and drug treatment.Drugs,2003;64(4):353~65.
  • 4National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing.Ninth informational supplement M100-S9,NCCLS,1999;19(1):72~5.
  • 5Bush K,Jacoby GA,Medeiros AA.A functional classification scheme for β-lactamases and its correlation with molecular structure.Antimicrob Agents Chemother,1995;39(6):1211~33.
  • 6Canton R,Coque TM,Oliver A et al.Epidemiology of extended-spectrum β-lactamase-producing enterobacter isolates in a spanish hospital during a 12-year period.J Clin Microbiol,2002;40(4):1237~43.
  • 7Jesus RB,Muniain MA,Perea EJ.Epdemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.J Clin Microbiol,2004;42(3):1089~94.
  • 8Bradford PA.Exteded-spectrum β-Lactamases in the 21st century:characterization,epidemiology,and detection of this important resistance threat.Clin Microbiol Rev,2001;14(4):933~51.
  • 9Yang Y,Bhachech N,Bradford PA et al.Ceftazidime resistant Klebsiella pneumoniae and escherichia coli isolates producing TEM-10 and TEM-43 β-lactamases from St.Louis,Missouri.Antimicrob Agents Chemother,1998;42(7):1671~6.
  • 10Palucha A,Mikliewicz B,Hryniewicz W,et al.Concurrent ourbreaks of extended-spectrum β-lactamases producing organisms of the family enter obacteriacae in a Wars hospital.J Amt-imixrob Chemother,1999,44:489

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部